The global Liver Cancer Diagnostics Market is valued at USD 11.4 billion in 2026 and is projected to reach USD 25.8 billion by 2036, expanding at a CAGR of 8.5%. Having stood at USD 10.6 billion in 2025, the market reflects a strong growth trajectory driven by precision diagnostics, AI integration, and increasing global cancer screening demand. The Liver Cancer Diagnostics Market is gaining strategic importance as healthcare systems prioritize early detection, staging...

The global Surgical Navigation System Market is projected to grow from an estimated USD 1,235.7 million in 2025 to USD 2,255.2 million by 2035, expanding at a CAGR of 6.2% during the forecast period. Rising demand for minimally invasive surgeries, increasing chronic disease burden, and advancements in imaging and AI-assisted technologies are accelerating adoption. The market’s growth reflects a broader shift toward precision-driven surgical outcomes and improved patient...

NEWARK, DE | 20 Mar 2026 —The global microfluidic organ-on-chip drug testing market is entering a rapid growth phase as pharmaceutical and biotechnology companies transition from traditional animal and static cell-based assays to dynamic, human-relevant predictive models. Valued at USD 141.5 million in 2025, the market is projected to reach USD 168.0 million in 2026 and surge to USD 932.9 million by 2036, expanding at a robust CAGR of 18.7% during the forecast period. According to...

NEWARK, DE | The Exosome-Based Neurodegenerative Disease Therapeutics Market, valued at USD 25.9 million in 2025, is projected to reach USD 32.8 million in 2026 and expand rapidly to USD 352.5 million by 2036, registering a CAGR of 26.80% during the forecast period. This growth reflects a structural shift in neurology drug development, as traditional small molecules fail to cross the blood-brain barrier effectively, pushing the industry toward biological lipid-bilayer delivery...

NEWARK, DE | The Pre-Filled Syringe Cell Therapy Delivery Systems Market was valued at USD 145.0 million in 2025 and is projected to reach USD 160.4 million in 2026. Expanding at a CAGR of 10.60%, the market is forecast to reach USD 424.4 million by 2036. This growth reflects a structural shift toward point-of-care delivery systems that preserve cellular viability while eliminating risks associated with traditional vial-based workflows. Market snapshot: global market 2026 -...

NEWARK, DE | The Tylosin market is projected to expand from USD 0.8 billion in 2025 to USD 0.9 billion in 2026, advancing at a CAGR of 4.9% through the forecast period. The market is expected to reach USD 1.3 billion by 2036, driven by evolving livestock management practices and tightening antimicrobial resistance frameworks. This growth reflects a structural shift toward targeted therapeutic interventions and precision veterinary compliance systems. Market snapshot: global...

NEWARK, DE | The Algorithmic Clinical Audit Trail Market was valued at USD 1.2 billion in 2025 and is projected to reach USD 1.5 billion in 2026, expanding at a CAGR of 12.14% through 2036. Sustained regulatory pressure and the need for immutable provenance in AI-driven clinical systems are expected to drive the market to USD 4.7 billion by 2036. This growth reflects a structural shift from traditional IT logs to cryptographic audit systems that enable compliance,...

NEWARK, DE | The Detachable Embolization Coils Market surpassed USD 1.5 billion in 2025 and is projected to cross USD 1.6 billion in 2026. Expanding at a CAGR of 5.7% through 2036, the market is expected to reach USD 2.8 billion, driven by the accelerating shift toward minimally invasive endovascular coiling over high-risk surgical clipping. This transition is particularly significant as healthcare systems increasingly manage smaller and more complex neurovascular conditions....

NEWARK, DE | The Clinical Documentation Integrity Automation Market is projected to grow from USD 2.1 billion in 2025 to USD 2.4 billion in 2026, advancing at a CAGR of 14.50% through 2036. Sustained investment and the shift toward value-based care models are expected to propel the market to USD 9.3 billion by 2036. The transformation reflects a structural push by healthcare systems to eliminate reimbursement leakage caused by undocumented patient acuity. Read Full...

NEWARK, DE — The Radiology Structured Reporting Automation market was valued at USD 1.1 billion in 2025 and is projected to reach USD 3.5 billion by 2036, expanding at a CAGR of 11.30%. The market is expected to grow from USD 1.2 billion in 2026, driven by mandatory discrete data extraction requirements and the rapid transition away from free-text radiology dictation. This shift is fundamentally reshaping diagnostic workflows and reimbursement models across global...

NEWARK, DE | The Provider Directory Accuracy Management Market is valued at USD 1.2 billion in 2025 and is projected to reach USD 4.8 billion by 2036, expanding at a CAGR of 13.11%. The market is expected to reach USD 1.4 billion in 2026, driven by regulatory mandates and the urgent need for real-time provider data validation. As compliance pressures intensify, accurate provider directories are becoming mission-critical for health plans globally. Read Full...

NEWARK, DE The Revenue Cycle Denials Intelligence Market was valued at USD 2.1 billion in 2025 and is projected to reach USD 2.4 billion in 2026, advancing at a CAGR of 12.50% through the forecast period. By 2036, the market is expected to reach USD 7.8 billion, driven by healthcare providers adopting predictive intelligence solutions to counter automated payer claim denials and safeguard financial performance. As payer adjudication systems become increasingly algorithmic,...